SB202190

SB202190

Contact us: [email protected]

SB202190 (p38 MAP kinase inhibitor)
SIH-473-5MG 5 mg
EUR 192
Description: The substance SB202190 is a p38 map kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is pale yellow solid which is soluble in methanol, DMSO or acetone; slightly soluble in ethyl acetate.

SB-431542
1674-1 each
EUR 202.8

SB-431542
1674-5 each
EUR 535.2

SB-715992
2468-25 each
EUR 836.4

SB-715992
2468-5 each
EUR 261.6

SB-525334
2880-25 each
EUR 757.2

SB-525334
2880-5 each
EUR 235.2

SB-222200
A3795-10 10 mg
EUR 240
Description: SB 222200 is a selective and potent antagonist of NK-3 receptor [1].Neurokinin-3 (NK-3) receptor is a member of the G-protein-coupled superfamily and functions as a receptor for tachykinin.

SB-222200
A3795-5.1 10 mM (in 1mL DMSO)
EUR 258
Description: SB 222200 is a selective and potent antagonist of NK-3 receptor [1].Neurokinin-3 (NK-3) receptor is a member of the G-protein-coupled superfamily and functions as a receptor for tachykinin.

SB-222200
A3795-50 50 mg
EUR 841.2
Description: SB 222200 is a selective and potent antagonist of NK-3 receptor [1].Neurokinin-3 (NK-3) receptor is a member of the G-protein-coupled superfamily and functions as a receptor for tachykinin.

SB-674042
A3800-10 10 mg
EUR 350.4
Description: SB-674042 is a specific, high-affinity OX1 selective antagonist.

SB-674042
A3800-25 25 mg
EUR 717.6
Description: SB-674042 is a specific, high-affinity OX1 selective antagonist.

SB-674042
A3800-5 5 mg
EUR 216
Description: SB-674042 is a specific, high-affinity OX1 selective antagonist.

SB-742457
9568-25 each
EUR 652.8

SB-742457
9568-5 each
EUR 210

SB525334
A5602-100 100 mg
EUR 727.2
Description: SB525334 is a potent inhibitor of transforming growth factor-beta1 (TGF-beta1) receptor, activin receptor-like kinase (ALK5). It specifically inhibits ALK5 with IC50 value of 14.3nM, which shows 4-fold higher potency against ALK4 [1].

SB525334
A5602-25 25 mg
EUR 268.8
Description: SB525334 is a potent inhibitor of transforming growth factor-beta1 (TGF-beta1) receptor, activin receptor-like kinase (ALK5). It specifically inhibits ALK5 with IC50 value of 14.3nM, which shows 4-fold higher potency against ALK4 [1].

SB525334
A5602-5 5 mg
EUR 129.6
Description: SB525334 is a potent inhibitor of transforming growth factor-beta1 (TGF-beta1) receptor, activin receptor-like kinase (ALK5). It specifically inhibits ALK5 with IC50 value of 14.3nM, which shows 4-fold higher potency against ALK4 [1].

SB525334
A5602-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: SB525334 is a potent inhibitor of transforming growth factor-beta1 (TGF-beta1) receptor, activin receptor-like kinase (ALK5). It specifically inhibits ALK5 with IC50 value of 14.3nM, which shows 4-fold higher potency against ALK4 [1].

SB525334
A5602-S Evaluation Sample
EUR 97.2
Description: SB525334 is a potent inhibitor of transforming growth factor-beta1 (TGF-beta1) receptor, activin receptor-like kinase (ALK5). It specifically inhibits ALK5 with IC50 value of 14.3nM, which shows 4-fold higher potency against ALK4 [1].

SB705498
A8519-10 10 mg
EUR 268.8
Description: PKi: 7.6 for human TRPV1 receptor Vanilloid receptor-1 (TRPV1) is a nonselective cation channel, predominantly expressed by sensory neurons, playing a key role in the detection of noxious painful stimuli such as capsaicin, heat, and acid.

SB705498
A8519-5 5 mg
EUR 170.4
Description: PKi: 7.6 for human TRPV1 receptor Vanilloid receptor-1 (TRPV1) is a nonselective cation channel, predominantly expressed by sensory neurons, playing a key role in the detection of noxious painful stimuli such as capsaicin, heat, and acid.

SB705498
A8519-5.1 10 mM (in 1mL DMSO)
EUR 181.2
Description: PKi: 7.6 for human TRPV1 receptor Vanilloid receptor-1 (TRPV1) is a nonselective cation channel, predominantly expressed by sensory neurons, playing a key role in the detection of noxious painful stimuli such as capsaicin, heat, and acid.

SB705498
A8519-50 50 mg
EUR 964.8
Description: PKi: 7.6 for human TRPV1 receptor Vanilloid receptor-1 (TRPV1) is a nonselective cation channel, predominantly expressed by sensory neurons, playing a key role in the detection of noxious painful stimuli such as capsaicin, heat, and acid.

SB-415286
B1954-25 each
EUR 907.2

SB-415286
B1954-5 each
EUR 274.8

SB-334867
B1281-10 10 mg
EUR 184.8
Description: SB-334867 is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867
B1281-25 25 mg
EUR 324
Description: SB-334867 is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867
B1281-5 5 mg
EUR 132
Description: SB-334867 is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867
B1281-5.1 10 mM (in 1mL DMSO)
EUR 142.8
Description: SB-334867 is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867
B1281-50 50 mg
EUR 482.4
Description: SB-334867 is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB590885
B1406-10 10 mg
EUR 226.8
Description: SB590885 is a potent and selective inhibitor of B-Raf kinase with Ki value of 0.16nM [1].SB590885 is a potent inhibitor of oncogenic B-Raf protein kinase with Ki value of 0.16nM.

SB590885
B1406-100 100 mg
EUR 1144.8
Description: SB590885 is a potent and selective inhibitor of B-Raf kinase with Ki value of 0.16nM [1].SB590885 is a potent inhibitor of oncogenic B-Raf protein kinase with Ki value of 0.16nM.

SB590885
B1406-250 250 mg
EUR 1980
Description: SB590885 is a potent and selective inhibitor of B-Raf kinase with Ki value of 0.16nM [1].SB590885 is a potent inhibitor of oncogenic B-Raf protein kinase with Ki value of 0.16nM.

SB590885
B1406-5.1 10 mM (in 1mL DMSO)
EUR 268.8
Description: SB590885 is a potent and selective inhibitor of B-Raf kinase with Ki value of 0.16nM [1].SB590885 is a potent inhibitor of oncogenic B-Raf protein kinase with Ki value of 0.16nM.

SB590885
B1406-50 50 mg
EUR 727.2
Description: SB590885 is a potent and selective inhibitor of B-Raf kinase with Ki value of 0.16nM [1].SB590885 is a potent inhibitor of oncogenic B-Raf protein kinase with Ki value of 0.16nM.

SB743921
B1590-10 10 mg
EUR 350.4
Description: SB743921 is an inhibitor of kinesin spindle protein (KSP) with Ki value of 0.1nM [1].As an inhibitor of mitotic kinesin KSP, SB743921 causes cell cycle arrest in mitosis, results in cell death.

SB743921
B1590-200 200 mg
EUR 2346
Description: SB743921 is an inhibitor of kinesin spindle protein (KSP) with Ki value of 0.1nM [1].As an inhibitor of mitotic kinesin KSP, SB743921 causes cell cycle arrest in mitosis, results in cell death.

SB743921
B1590-50 50 mg
EUR 957.6
Description: SB743921 is an inhibitor of kinesin spindle protein (KSP) with Ki value of 0.1nM [1].As an inhibitor of mitotic kinesin KSP, SB743921 causes cell cycle arrest in mitosis, results in cell death.

SB239063
B1699-25 each
EUR 652.8

SB239063
B1699-5 each
EUR 210

SB-590885
B1708-25 each
EUR 652.8

SB-590885
B1708-5 each
EUR 210

SB-366791
20-abx076632
  • EUR 376.80
  • EUR 1028.40
  • 10 mg
  • 50 mg

SB216763
20-abx076766
  • EUR 828.00
  • EUR 376.80
  • 25 mg
  • 5 mg

SB431542
20-abx076786
  • EUR 1045.20
  • EUR 410.40
  • 25 mg
  • 5 mg

SB203580
20-abx076800
  • EUR 1395.60
  • EUR 510.00
  • 25 mg
  • 5 mg

SB273005
B6003-25 25 mg
EUR 734.4
Description: SB 273005 is a potent nonpeptide antagonist of ?v?3 (vitronectin receptor), with Ki values of 1.2 nM and 0.3 nM to two closely related integrins, ?v?3 and ?v?5, respectively [1].

SB273005
B6003-5 5 mg
EUR 254.4
Description: SB 273005 is a potent nonpeptide antagonist of ?v?3 (vitronectin receptor), with Ki values of 1.2 nM and 0.3 nM to two closely related integrins, ?v?3 and ?v?5, respectively [1].

SB408124
B2163-10 10 mg
EUR 254.4
Description: SB408124 is a potent and novel nonpeptide antagonist of orexin-1 (OX(1)) receptor with Ki values of 27 nM and 57 nM in membrane formats and in whole cell, respectively. SB408124 was 50-fold selective over the human OX2 receptor [1].

SB408124
B2163-25 25 mg
EUR 494.4
Description: SB408124 is a potent and novel nonpeptide antagonist of orexin-1 (OX(1)) receptor with Ki values of 27 nM and 57 nM in membrane formats and in whole cell, respectively. SB408124 was 50-fold selective over the human OX2 receptor [1].

SB408124
B2163-5 5 mg
EUR 166.8
Description: SB408124 is a potent and novel nonpeptide antagonist of orexin-1 (OX(1)) receptor with Ki values of 27 nM and 57 nM in membrane formats and in whole cell, respectively. SB408124 was 50-fold selective over the human OX2 receptor [1].

SB408124
B2163-50 50 mg
EUR 710.4
Description: SB408124 is a potent and novel nonpeptide antagonist of orexin-1 (OX(1)) receptor with Ki values of 27 nM and 57 nM in membrane formats and in whole cell, respectively. SB408124 was 50-fold selective over the human OX2 receptor [1].

SB271046
B2255-10 10 mg
EUR 201.6
Description: SB-271046 is a selective and orally active 5-HT6 receptor antagonist.5-HT6 belongs to GPCR which stimulates adenylate cyclase via Gs, which cloned from rat striatum.

SB271046
B2255-50 50 mg
EUR 614.4
Description: SB-271046 is a selective and orally active 5-HT6 receptor antagonist.5-HT6 belongs to GPCR which stimulates adenylate cyclase via Gs, which cloned from rat striatum.

SB271046
B2255-S Evaluation Sample
EUR 97.2
Description: SB-271046 is a selective and orally active 5-HT6 receptor antagonist.5-HT6 belongs to GPCR which stimulates adenylate cyclase via Gs, which cloned from rat striatum.

SB742457
B2256-25 25 mg
EUR 518.4
Description: SB742457 is a selective antagonist of 5-HT6 receptor with a pKi value of 9.63 [1].SB742457 has been found to be a highly selective 5-HT6 receptor antagonist with high affinity to human 5-HT6 receptor.

SB742457
B2256-5 5 mg
EUR 205.2
Description: SB742457 is a selective antagonist of 5-HT6 receptor with a pKi value of 9.63 [1].SB742457 has been found to be a highly selective 5-HT6 receptor antagonist with high affinity to human 5-HT6 receptor.

SB742457
B2256-5.1 10 mM (in 1mL DMSO)
EUR 278.4
Description: SB742457 is a selective antagonist of 5-HT6 receptor with a pKi value of 9.63 [1].SB742457 has been found to be a highly selective 5-HT6 receptor antagonist with high affinity to human 5-HT6 receptor.

SB-242235
B2273-25 each
EUR 614.4

SB-242235
B2273-5 each
EUR 210

SB505124
B2289-10 10 mg
EUR 226.8
Description: SB505124 is a selective and small molecule inhibitor of transforming growth Factor- ? type 1 receptors ALK4, ALK5 and ALK7 with the IC50 values of 129±11nM and 47±5nM for ALK4 and ALK5, respectively.

SB505124
B2289-50 50 mg
EUR 630
Description: SB505124 is a selective and small molecule inhibitor of transforming growth Factor- ? type 1 receptors ALK4, ALK5 and ALK7 with the IC50 values of 129±11nM and 47±5nM for ALK4 and ALK5, respectively.

SB-204490
B2507-1 each
EUR 157.2

SB-204490
B2507-5 each
EUR 418.8

SB-297006
B2589-25 each
EUR 548.4

SB-297006
B2589-5 each
EUR 183.6

SB-408124
E1KS1545 5mg
EUR 390

SB590885
E1KS2220 10mg
EUR 625.2

SB-366791
GL6242-25MG 25 mg
EUR 385.2

SB-366791
GL6242-5MG 5 mg
EUR 157.2

SB-431542
HY-10431 100mg
EUR 985.2

SB-705498
HY-10633 100mg
EUR 1795.2

SB-657510
HY-10656 10mg
EUR 1135.2

SB-649868
HY-10806 100mg
EUR 4936.8

SB-277011
HY-10847 50mg
EUR 1315.2

SB-334867
HY-10895 50mg
EUR 589.2

SB-674042
HY-10898 10mM/1mL
EUR 240

SB-590885
HY-10966 10mM/1mL
EUR 306

SB-743921
HY-12069 100mg
EUR 1630.8

SB-366791
HY-12245 10mg
EUR 176.4

SB269652
HY-12324 100mg
EUR 3531.6

SB-568849
HY-100308 10mg
EUR 3370.8

SB756050
HY-102016 50mg
EUR 2539.2

SB228357
HY-103154 5mg
EUR 680.4

SB297006
HY-103361 5mg
EUR 170.4

SB-505124
HY-13521 50mg
EUR 753.6

SB-423562
HY-15105 10mg
EUR 14160

SB-269970
HY-15370 50mg
EUR 854.4

SB-222200
HY-15722 10mg
EUR 274.8

SB225002
HY-16711 100mg
EUR 734.4

SB-265610
HY-50688 10mM/1mL
EUR 1802.4

SB-408124
HY-70068 10mM/1mL
EUR 153.6

SB269970 HCl
B2254-10 10 mg
EUR 297.6
Description: SB269970 HCl is a potent and selective antagonist of 5-HT7 receptor with pKi value of 8.3 [1].SB269970 is a selective antagonist of 5-HT7 receptor. It shows at least 100-fold selective against 5-HT7 over a variety of receptors and enzymes

SB269970 HCl
B2254-25 25 mg
EUR 591.6
Description: SB269970 HCl is a potent and selective antagonist of 5-HT7 receptor with pKi value of 8.3 [1].SB269970 is a selective antagonist of 5-HT7 receptor. It shows at least 100-fold selective against 5-HT7 over a variety of receptors and enzymes

SB269970 HCl
B2254-5 5 mg
EUR 184.8
Description: SB269970 HCl is a potent and selective antagonist of 5-HT7 receptor with pKi value of 8.3 [1].SB269970 is a selective antagonist of 5-HT7 receptor. It shows at least 100-fold selective against 5-HT7 over a variety of receptors and enzymes

SB269970 HCl
B2254-50 50 mg
EUR 999.6
Description: SB269970 HCl is a potent and selective antagonist of 5-HT7 receptor with pKi value of 8.3 [1].SB269970 is a selective antagonist of 5-HT7 receptor. It shows at least 100-fold selective against 5-HT7 over a variety of receptors and enzymes

SB-616234A
HY-19477 10mg
EUR 16242

SB-334867 free base
B3423-100 100 mg
EUR 718.8
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867 free base
B3423-25 25 mg
EUR 348
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867 free base
B3423-5 5 mg
EUR 153.6
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867 free base
B3423-5.1 10 mM (in 1mL DMSO)
EUR 157.2
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867 (free base)
HY-10895A 10mg
EUR 258

Ispinesib (SB-715992)
A5343-10 10 mg
EUR 324
Description: Ispinesib (SB-715992) is a selective inhibitor of KSP with IC50 value of 0.5 nM [1]. Kinesin spindle protein (KSP) is a kinesin motor protein and plays an important role in the formation of a bipolar mitotic spindle and cell cycle progression through mitosis.

Ispinesib (SB-715992)
A5343-100 100 mg
EUR 1423.2
Description: Ispinesib (SB-715992) is a selective inhibitor of KSP with IC50 value of 0.5 nM [1]. Kinesin spindle protein (KSP) is a kinesin motor protein and plays an important role in the formation of a bipolar mitotic spindle and cell cycle progression through mitosis.

Ispinesib (SB-715992)
A5343-5 5 mg
EUR 234
Description: Ispinesib (SB-715992) is a selective inhibitor of KSP with IC50 value of 0.5 nM [1]. Kinesin spindle protein (KSP) is a kinesin motor protein and plays an important role in the formation of a bipolar mitotic spindle and cell cycle progression through mitosis.

Ispinesib (SB-715992)
A5343-5.1 10 mM (in 1mL DMSO)
EUR 452.4
Description: Ispinesib (SB-715992) is a selective inhibitor of KSP with IC50 value of 0.5 nM [1]. Kinesin spindle protein (KSP) is a kinesin motor protein and plays an important role in the formation of a bipolar mitotic spindle and cell cycle progression through mitosis.

Ispinesib (SB-715992)
A5343-50 50 mg
EUR 1005.6
Description: Ispinesib (SB-715992) is a selective inhibitor of KSP with IC50 value of 0.5 nM [1]. Kinesin spindle protein (KSP) is a kinesin motor protein and plays an important role in the formation of a bipolar mitotic spindle and cell cycle progression through mitosis.

Ispinesib (SB-715992)
E1KS1452 5mg
EUR 1048.8

EZSolution? SB-431542
1872-1 each
EUR 189.6

EZSolution? SB-525334
2881-5 each
EUR 248.4

Cilomilast (SB-207499)
E1KS1455 5mg
EUR 625.2

SB-366791 (TRPV1 blocker)
SIH-321-10MG 10 mg
EUR 214.8
Description: The substance SB-366791 is a trpv1 blocker. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 10 mM in ethanol and to 100 mM in DMSO.

SB-366791 (TRPV1 blocker)
SIH-321-50MG 50 mg
EUR 698.4
Description: The substance SB-366791 is a trpv1 blocker. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 10 mM in ethanol and to 100 mM in DMSO.

SB-408124 Hydrochloride
A3798-10 10 mg
EUR 254.4
Description: SB-408124 (SB 408124) is a selective non-peptide orexin OX1 receptor antagonist .(Kb values are 21.7 and 1405 nM for human OX1 and OX2 receptors respectively). SB-408124 (SB 408124) blocks orexin-A induced grooming following oral administration in vivo.

SB-408124 Hydrochloride
A3798-100 100 mg
EUR 1144.8
Description: SB-408124 (SB 408124) is a selective non-peptide orexin OX1 receptor antagonist .(Kb values are 21.7 and 1405 nM for human OX1 and OX2 receptors respectively). SB-408124 (SB 408124) blocks orexin-A induced grooming following oral administration in vivo.

SB-408124 Hydrochloride
A3798-5 5 mg
EUR 189.6
Description: SB-408124 (SB 408124) is a selective non-peptide orexin OX1 receptor antagonist .(Kb values are 21.7 and 1405 nM for human OX1 and OX2 receptors respectively). SB-408124 (SB 408124) blocks orexin-A induced grooming following oral administration in vivo.

SB-408124 Hydrochloride
A3798-5.1 10 mM (in 1mL DMSO)
EUR 201.6
Description: SB-408124 (SB 408124) is a selective non-peptide orexin OX1 receptor antagonist .(Kb values are 21.7 and 1405 nM for human OX1 and OX2 receptors respectively). SB-408124 (SB 408124) blocks orexin-A induced grooming following oral administration in vivo.

SB-408124 Hydrochloride
A3798-50 50 mg
EUR 667.2
Description: SB-408124 (SB 408124) is a selective non-peptide orexin OX1 receptor antagonist .(Kb values are 21.7 and 1405 nM for human OX1 and OX2 receptors respectively). SB-408124 (SB 408124) blocks orexin-A induced grooming following oral administration in vivo.

SB-505124 hydrochloride
A3799-10 10 mg
EUR 226.8
Description: SB505124 is a selective inhibitor of TGF?R for ALK4, ALK5 with IC50 value of 129 nM and 47 nM [1].Anaplastic lymphoma kinase (ALK) gets involved in the development of the brain and influence specific neurons in the nervous system.

SB-505124 hydrochloride
A3799-5.1 10 mM (in 1mL DMSO)
EUR 170.4
Description: SB505124 is a selective inhibitor of TGF?R for ALK4, ALK5 with IC50 value of 129 nM and 47 nM [1].Anaplastic lymphoma kinase (ALK) gets involved in the development of the brain and influence specific neurons in the nervous system.

SB-505124 hydrochloride
A3799-50 50 mg
EUR 630
Description: SB505124 is a selective inhibitor of TGF?R for ALK4, ALK5 with IC50 value of 129 nM and 47 nM [1].Anaplastic lymphoma kinase (ALK) gets involved in the development of the brain and influence specific neurons in the nervous system.

Eltrombopag (SB-497115-GR)
E1KS2229 5mg
EUR 625.2

SB-224289 hydrochloride
HY-101105A 10mM/1mL
EUR 222

SB-399885 hydrochloride
HY-103099 100mg
EUR 1879.2

SB-505124 (hydrochloride)
HY-13521A 10mg
EUR 258

SB-269970 (hydrochloride)
HY-15370A 10mM/1mL
EUR 322.8

SB-408124 (Hydrochloride)
HY-76612 10mM/1mL
EUR 169.2

SB203580 (p38 MAP kinase inhibitor)
SIH-474-25MG 25 mg
EUR 985.2
Description: The substance SB203580 is a p38 map kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white powder which is soluble in DMSO (50 mg/ml).

SB203580 (p38 MAP kinase inhibitor)
SIH-474-5MG 5 mg
EUR 313.2
Description: The substance SB203580 is a p38 map kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white powder which is soluble in DMSO (50 mg/ml).

SB216763 (GSK-3 kinase inhibitor)
SIH-510-25MG 25 mg
EUR 548.4
Description: The substance SB216763 is a gsk-3 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is orange solid which is soluble in DMSO (>25 mg/ml).

SB216763 (GSK-3 kinase inhibitor)
SIH-510-5MG 5 mg
EUR 205.2
Description: The substance SB216763 is a gsk-3 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is orange solid which is soluble in DMSO (>25 mg/ml).

SB1317
A3794-10 10 mg
EUR 390
Description: SB1317 is a potent inhibitor of Cyclin dependent kinases (CDKs), FMS-like tyrosine kinase-3 (FLT3) and Janus kinase 2 (JAK2) with IC50 values of 13nM, 56nM and 73nM for CDK2, JAK2 and FLT3, respectively [1].

SB1317
A3794-100 100 mg
EUR 1243.2
Description: SB1317 is a potent inhibitor of Cyclin dependent kinases (CDKs), FMS-like tyrosine kinase-3 (FLT3) and Janus kinase 2 (JAK2) with IC50 values of 13nM, 56nM and 73nM for CDK2, JAK2 and FLT3, respectively [1].

SB1317
A3794-5 5 mg
EUR 278.4
Description: SB1317 is a potent inhibitor of Cyclin dependent kinases (CDKs), FMS-like tyrosine kinase-3 (FLT3) and Janus kinase 2 (JAK2) with IC50 values of 13nM, 56nM and 73nM for CDK2, JAK2 and FLT3, respectively [1].

SB1317
A3794-50 50 mg
EUR 783.6
Description: SB1317 is a potent inhibitor of Cyclin dependent kinases (CDKs), FMS-like tyrosine kinase-3 (FLT3) and Janus kinase 2 (JAK2) with IC50 values of 13nM, 56nM and 73nM for CDK2, JAK2 and FLT3, respectively [1].

Sb1317
20-abx182646
  • EUR 2380.80
  • EUR 794.40
  • 100 mg
  • 10 mg

SB1317
HY-15166 10mM/1mL
EUR 226.8

SB-772077B dihydrochloride
HY-108518 5mg
EUR 418.8

SB290157 (trifluoroacetate)
HY-101502A 50mg
EUR 538.8

SB431542 (ALK4,5 and 7 kinase inhibitor)
SIH-511-25MG 25 mg
EUR 716.4
Description: The substance SB431542 is a alk4,5 and 7 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow solid which is soluble to 10 mM in ethanol and to 100 mM in DMSO.

SB431542 (ALK4,5 and 7 kinase inhibitor)
SIH-511-5MG 5 mg
EUR 238.8
Description: The substance SB431542 is a alk4,5 and 7 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow solid which is soluble to 10 mM in ethanol and to 100 mM in DMSO.

SB-203580 p38 MAPK(p38 MAP kinase) Inhibitor
E1B1863 1mg
EUR 193.2

VS-5584 (SB2343)
A3927-10 10 mg
EUR 226.8
Description: VS-5584 (SB2343), a purine analog, is a novel small-molecule inhibitor of both mammalian target of rapamycin (mTOR) kinase and all class I phosphoinostide 3-kinase (PI3K) isoforms that ATP-competitively inhibits the activity of mTOR, PI3K?, PI3K?, PI3K? and PI3K?.

VS-5584 (SB2343)
A3927-5 5 mg
EUR 184.8
Description: VS-5584 (SB2343), a purine analog, is a novel small-molecule inhibitor of both mammalian target of rapamycin (mTOR) kinase and all class I phosphoinostide 3-kinase (PI3K) isoforms that ATP-competitively inhibits the activity of mTOR, PI3K?, PI3K?, PI3K? and PI3K?.

VS-5584 (SB2343)
A3927-5.1 10 mM (in 1mL DMSO)
EUR 196.8
Description: VS-5584 (SB2343), a purine analog, is a novel small-molecule inhibitor of both mammalian target of rapamycin (mTOR) kinase and all class I phosphoinostide 3-kinase (PI3K) isoforms that ATP-competitively inhibits the activity of mTOR, PI3K?, PI3K?, PI3K? and PI3K?.

VS-5584 (SB2343)
A3927-50 50 mg
EUR 616.8
Description: VS-5584 (SB2343), a purine analog, is a novel small-molecule inhibitor of both mammalian target of rapamycin (mTOR) kinase and all class I phosphoinostide 3-kinase (PI3K) isoforms that ATP-competitively inhibits the activity of mTOR, PI3K?, PI3K?, PI3K? and PI3K?.

VS-5584 (SB2343)
A3927-S Evaluation Sample
EUR 97.2
Description: VS-5584 (SB2343), a purine analog, is a novel small-molecule inhibitor of both mammalian target of rapamycin (mTOR) kinase and all class I phosphoinostide 3-kinase (PI3K) isoforms that ATP-competitively inhibits the activity of mTOR, PI3K?, PI3K?, PI3K? and PI3K?.

EZSolution? SB-431542, Sterile-Filtered
1992-1 each
EUR 326.4

Stuart Hotplate SB500 1500W
HOT1086 EACH
EUR 866.4

SB1518 (Pacritinib)
2450-1 each
EUR 210

SB1518 (Pacritinib)
2450-5 each
EUR 652.8

Pacritinib (SB1518)
B1589-10 10 mg
EUR 532.8
Description: Pacritinib is a small molecule inhibitor of Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) with IC50 values of 23nM, 19nM and 22nM, respectively for JAK2WT, JAK2V617F and FLT3 [1].

Pacritinib (SB1518)
B1589-25 25 mg
EUR 1104
Description: Pacritinib is a small molecule inhibitor of Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) with IC50 values of 23nM, 19nM and 22nM, respectively for JAK2WT, JAK2V617F and FLT3 [1].

Pacritinib (SB1518)
B1589-5 5 mg
EUR 348
Description: Pacritinib is a small molecule inhibitor of Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) with IC50 values of 23nM, 19nM and 22nM, respectively for JAK2WT, JAK2V617F and FLT3 [1].

Pacritinib (SB1518)
B1589-5.1 10 mM (in 1mL DMSO)
EUR 602.4
Description: Pacritinib is a small molecule inhibitor of Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) with IC50 values of 23nM, 19nM and 22nM, respectively for JAK2WT, JAK2V617F and FLT3 [1].

Pacritinib (SB1518)
B1589-50 50 mg
EUR 2005.2
Description: Pacritinib is a small molecule inhibitor of Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) with IC50 values of 23nM, 19nM and 22nM, respectively for JAK2WT, JAK2V617F and FLT3 [1].

SB939
E1KS1515 50mg
EUR 4164

pCMV (CAT)T7- SB100
PVT10879 2 ug
EUR 361.2

Glass Stopper Hollow SB1423 Quickfit
QSB140 PK5
EUR 40.8

Stuart Stirrer Hotplate SB162-3 3 Place
STI2313 EACH
EUR 1566

Monoclonal KCNJ12 / Kir2.2 Antibody (aa362-427, clone S124B-38), Clone: S124B-38
AMM06101G 0.05mg
EUR 580.8
Description: A Monoclonal antibody against Human KCNJ12 / Kir2.2 (aa362-427, clone S124B-38). The antibodies are raised in Mouse and are from clone S124B-38. This antibody is applicable in WB and IHC-P, IF, ICC

Pracinostat (SB939)
27771-1 10 mg
EUR 275
Description: Potent and oral inhibitor of histone deacetylase (HDAC), selective for class I, II and IV HDACs. SB939 shows significant antiproliferative activity against a wide variety of tumor cell lines, with high tumor exposure and efficacy in mouse models of colorectal cancer.

Pracinostat (SB939)
27771-2 5 mg
EUR 190
Description: Potent and oral inhibitor of histone deacetylase (HDAC), selective for class I, II and IV HDACs. SB939 shows significant antiproliferative activity against a wide variety of tumor cell lines, with high tumor exposure and efficacy in mouse models of colorectal cancer.

Pracinostat (SB939)
27771-3 50 mg
EUR 700
Description: Potent and oral inhibitor of histone deacetylase (HDAC), selective for class I, II and IV HDACs. SB939 shows significant antiproliferative activity against a wide variety of tumor cell lines, with high tumor exposure and efficacy in mouse models of colorectal cancer.

Pracinostat (SB939)
A4095-10 10 mg
EUR 351.6
Description: Pracinostat, also known as SB939, is a potent and orally available inhibitor of histone deacetylase (HDAC) with a relatively stronger selectivity (more than 1000-fold) for class I, class II and class IV HDACs rather than class III HDACs.

Pracinostat (SB939)
A4095-5 5 mg
EUR 219.6
Description: Pracinostat, also known as SB939, is a potent and orally available inhibitor of histone deacetylase (HDAC) with a relatively stronger selectivity (more than 1000-fold) for class I, class II and class IV HDACs rather than class III HDACs.

Pracinostat (SB939)
A4095-5.1 10 mM (in 1mL DMSO)
EUR 236.4
Description: Pracinostat, also known as SB939, is a potent and orally available inhibitor of histone deacetylase (HDAC) with a relatively stronger selectivity (more than 1000-fold) for class I, class II and class IV HDACs rather than class III HDACs.

Pracinostat (SB939)
A4095-50 50 mg
EUR 908.4
Description: Pracinostat, also known as SB939, is a potent and orally available inhibitor of histone deacetylase (HDAC) with a relatively stronger selectivity (more than 1000-fold) for class I, class II and class IV HDACs rather than class III HDACs.

Pracinostat (SB939)
A4095-S Evaluation Sample
EUR 97.2
Description: Pracinostat, also known as SB939, is a potent and orally available inhibitor of histone deacetylase (HDAC) with a relatively stronger selectivity (more than 1000-fold) for class I, class II and class IV HDACs rather than class III HDACs.

Stuart SB300 Hotplate 600W
HOT1084 EACH
EUR 656.64

Stuart Magnetic Stirrer SB301
STI2015 EACH
EUR 917.84

S100B(S100B/1012) Antibody
BNC401012-100 100uL
EUR 238.8
Description: Primary antibody against S100B(S100B/1012), CF640R conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC401012-500 500uL
EUR 652.8
Description: Primary antibody against S100B(S100B/1012), CF640R conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC551012-100 100uL
EUR 238.8
Description: Primary antibody against S100B(S100B/1012), CF555 conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC551012-500 500uL
EUR 652.8
Description: Primary antibody against S100B(S100B/1012), CF555 conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC431012-100 100uL
EUR 238.8
Description: Primary antibody against S100B(S100B/1012), CF543 conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC431012-500 500uL
EUR 652.8
Description: Primary antibody against S100B(S100B/1012), CF543 conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC471012-100 100uL
EUR 238.8
Description: Primary antibody against S100B(S100B/1012), CF647 conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC471012-500 500uL
EUR 652.8
Description: Primary antibody against S100B(S100B/1012), CF647 conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC801012-100 100uL
EUR 238.8
Description: Primary antibody against S100B(S100B/1012), CF680 conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC801012-500 500uL
EUR 652.8
Description: Primary antibody against S100B(S100B/1012), CF680 conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC811012-100 100uL
EUR 238.8
Description: Primary antibody against S100B(S100B/1012), CF680R conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC811012-500 500uL
EUR 652.8
Description: Primary antibody against S100B(S100B/1012), CF680R conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC611012-100 100uL
EUR 238.8
Description: Primary antibody against S100B(S100B/1012), CF660R conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC611012-500 500uL
EUR 652.8
Description: Primary antibody against S100B(S100B/1012), CF660R conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNUM1012-50 50uL
EUR 474
Description: Primary antibody against S100B(S100B/1012), 1mg/mL

S100B(S100B/1012) Antibody
BNCP1012-250 250uL
EUR 459.6
Description: Primary antibody against S100B(S100B/1012), PerCP conjugate, Concentration: 0.1mg/mL

S100B(S100B/1012) Antibody
BNC941012-100 100uL
EUR 238.8
Description: Primary antibody against S100B(S100B/1012), CF594 conjugate, Concentration: 0.1mg/mL

SB202190